<DOC>
	<DOCNO>NCT00816907</DOCNO>
	<brief_summary>This study test usefulness medication metformin treat people schizophrenia schizoaffective disorder overweight also take antipsychotic medication .</brief_summary>
	<brief_title>The Use Metformin Treatment Antipsychotic-Induced Weight Gain Schizophrenia ( The METS Study )</brief_title>
	<detailed_description>Schizophrenia chronic mental disorder characterize , part , psychotic symptom . Psychotic symptom include hallucination delusion , person abnormal experience belief , commonly treat antipsychotic medication . Unfortunately , side effect many antipsychotic unwanted weight gain , lead physical illness . Use drug metformin result weight loss among diabetic . Metformin also show cause weight loss preliminary study people take atypical antipsychoticsâ€”a newer , second generation antipsychotic medication . Metformin currently approve Food Drug Administration treat people diabetes . This study test usefulness prescribe metformin second medication treat people schizophrenia schizoaffective disorder overweight take antipsychotic . The study also provide important feasibility information future large study . Participation study last 16 week . After undergo baseline assessment , participant randomly assign receive either metformin placebo , take twice daily duration study . All participant also receive behavioral therapy teach reduce weight diet exercise . Participants undergo assessment 11 study visit : first 2 include screen baseline testing , next 2 visit take place first second week receive treatment , last 7 visit take place every 2 week end study . Assessments include measurement body weight , waist-to-hip ratio , vital sign ; clinical interview medication adherence , side effect , alcohol use ; monthly blood test ass level lipid , glucose , insulin , hemoglobin A1c .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Outpatients diagnosis schizophrenia schizoaffective disorder , define DSMIVTR criterion confirm Structured Clinical Interview DSMIV ( SCID ) Duration illness great 1 year , define initiated antipsychotic treatment least 1 year prior study entry Adequate decisional capacity make choice participate research study Body mass index ( BMI ) great 27 Currently treat one combination two antipsychotic medication ( typical atypical ) drug regimen least 2 month prior study entry , stable dosage least 1 month If take antidepressant , mood stabilizer , anxiolytic , dose must stable least 1 month prior study entry Willing use adequate method contraception avoid pregnancy throughout study 4 week study . Acceptable method include oral , injectable , implanted contraceptive ; intrauterine device barrier method condom ; diaphragms spermicide . Inpatient status Clinical Global Impression Severity ( CGIS ) score great 6 Currently treat two antipsychotic medication Fasting glucose great 125 Diagnosis diabetes mellitus treatment insulin oral hypoglycemics Previous current treatment metformin Diagnosis congestive heart failure Renal impairment , define serum creatinine level great 1.5 male great 1.4 female , creatinine estimate glomerular filtration rate ( GFR ) outside normal limit Hepatic disease , define aspartate transaminase ( AST ) , alanine transaminase ( ALT ) , cglutamyl transferase ( CGT ) great 1.5 time upper limit normal ( ULN ) , total bilirubin great 1.2 time ULN Metabolic acidosis , define serum carbon dioxide less low limit normal Known hypersensitivity metformin Pregnant breastfeeding Recent ( past 30 day ) schedule radiological study involve iodinated contrast material Alcohol abuse dependence within past month , determine SCID Other serious unstable medical condition judgment investigator Diagnosis mental retardation , delirium , dementia , define DSMIVTR Failed discontinue 4 week prior study entry medication use weight loss Concurrent treatment certain drug know increase metformin blood level discuss Project Medical Officer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Schizoaffective Disorder</keyword>
</DOC>